PYMNTS.com October 22, 2024

Hospitals are adopting AI assistants for patient care and Microsoft is rolling out medical imaging models, while the U.S. Food and Drug Administration (FDA) calls for vigilant monitoring of these rapidly evolving tools. The push toward AI integration promises to ease healthcare worker burnout and improve diagnostics, but regulators warn that these powerful new systems require continuous oversight to ensure patient safety.

FDA Calls for Monitoring of AI Medical Tools

According to a new FDA perspective published in JAMA, the Food and Drug Administration is pushing for continuous monitoring of artificial intelligence tools used in healthcare. The agency warns that unmonitored AI systems could pose risks to patient safety.

The agency, which has authorized nearly 1,000 AI-enabled medical devices to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Health System / Hospital, Provider, Technology
FDA commissioner talks about AI, drug shortages, and rethinking everything | HLTH 2024
AbbVie gets continuous Parkinson's drug over the line in US
FDA prioritizes guidance on lab developed tests in 2025 plan
Will ICER’s ‘shared savings’ approach decrease value-based prices most for the most severe diseases?
Opinion: STAT+: The biggest challenge facing the FDA’s new Rare Disease Innovation Hub

Share This Article